Interferon-gamma release assays for the diagnosis of TB pleural effusions: hype or real hope?
Authors:
- Yc Gary LeeYLYc Gary Lee
- Nick A MaskellNMNick A Maskell
- 1 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 15 (4) , 358-365
Abstract
T-cell interferon-gamma release assay (IGRA) use in tuberculosis (TB) contact screening and latent TB diagnosis is established and supported by American and European guidelines. However, questions remain regarding their clinical utility beyond conventional tests in the investigation of suspected active TB. We review the evidence base for IGRAs in the diagnosis or exclusion of pleural TB. The specificity of IGRAs for diagnosis of active TB disease is limited by an inability to distinguish latent disease. The test's sensitivity when applied to the blood of patients with active TB is diminished by compartmentalizing of sensitized T cells at the disease site. To circumnavigate these problems, recent studies explore the value of applying IGRAs to pleural fluid. Results have varied between patient populations, but the strategy does not appear to completely eliminate false-positive results. Accurate biomarkers of pleural TB are useful, particularly for their negative predictive value. IGRAs are technically more complicated and expensive than established biomarkers, and their diagnostic performance for active pleural TB is highly variable between studies and settings. Currently, there is inadequate evidence to support the use of IGRAs in the diagnosis or exclusion of active pleural TB, particularly in centres where adenosine deaminase and interferon-gamma assays are available.Keywords
This publication has 45 references indexed in Scilit:
- Evaluation of Adapted Whole-Blood Interferon-γ Release Assays for the Diagnosis of Pleural TuberculosisRespiration, 2008
- Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON®TB-Gold interferon-gamma assayBMC Infectious Diseases, 2008
- Diagnosis of Active Tuberculous Serositis by Antigen-Specific Interferon- Response of Cavity Fluid CellsClinical Infectious Diseases, 2007
- Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisyEuropean Respiratory Journal, 2007
- Low Sensitivity of a Whole‐Blood Interferon‐γ Release Assay for Detection of Active TuberculosisClinical Infectious Diseases, 2007
- Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practiceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis -Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active TuberculosisClinical and Vaccine Immunology, 2005
- Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2004
- Thoracoscopy--state of the artEuropean Respiratory Journal, 1998
- Tuberculous pleurisy and adenosine deaminase.Thorax, 1995